vs
Innoviva, Inc.（INVA）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Rocket Lab Corp的季度营收约是Innoviva, Inc.的1.6倍（$179.7M vs $114.6M），Innoviva, Inc.净利率更高（143.2% vs -29.5%，领先172.7%），Rocket Lab Corp同比增速更快（35.7% vs 24.8%），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 21.6%）
Innoviva Inc是一家专注于呼吸道疾病、传染病及重症护理领域处方治疗药物研发、商业化及特许权使用费管理的医疗保健企业，与全球领先制药商合作，为北美、欧洲等核心市场的患者提供哮喘、慢性阻塞性肺疾病等病症的治疗方案。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
INVA vs RKLB — 直观对比
营收规模更大
RKLB
是对方的1.6倍
$114.6M
营收增速更快
RKLB
高出10.9%
24.8%
净利率更高
INVA
高出172.7%
-29.5%
两年增速更快
RKLB
近两年复合增速
21.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.6M | $179.7M |
| 净利润 | $164.2M | $-52.9M |
| 毛利率 | 66.0% | 38.0% |
| 营业利润率 | 34.0% | -28.4% |
| 净利率 | 143.2% | -29.5% |
| 营收同比 | 24.8% | 35.7% |
| 净利润同比 | 707.4% | -1.1% |
| 每股收益（稀释后） | $2.19 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INVARKLB
| Q4 25 | $114.6M | $179.7M | ||
| Q3 25 | $107.8M | $155.1M | ||
| Q2 25 | $100.3M | $144.5M | ||
| Q1 25 | $88.6M | $122.6M | ||
| Q4 24 | $91.8M | $132.4M | ||
| Q3 24 | $89.5M | $104.8M | ||
| Q2 24 | $99.9M | $106.3M | ||
| Q1 24 | $77.5M | $92.8M |
净利润INVARKLB
| Q4 25 | $164.2M | $-52.9M | ||
| Q3 25 | $89.9M | $-18.3M | ||
| Q2 25 | $63.7M | $-66.4M | ||
| Q1 25 | $-46.6M | $-60.6M | ||
| Q4 24 | $20.3M | $-52.3M | ||
| Q3 24 | $1.2M | $-51.9M | ||
| Q2 24 | $-34.7M | $-41.6M | ||
| Q1 24 | $36.5M | $-44.3M |
毛利率INVARKLB
| Q4 25 | 66.0% | 38.0% | ||
| Q3 25 | 70.1% | 37.0% | ||
| Q2 25 | 82.9% | 32.1% | ||
| Q1 25 | 82.7% | 28.8% | ||
| Q4 24 | 85.1% | 27.8% | ||
| Q3 24 | 81.6% | 26.7% | ||
| Q2 24 | 85.1% | 25.6% | ||
| Q1 24 | 77.5% | 26.1% |
营业利润率INVARKLB
| Q4 25 | 34.0% | -28.4% | ||
| Q3 25 | 32.1% | -38.0% | ||
| Q2 25 | 48.6% | -41.3% | ||
| Q1 25 | 46.7% | -48.3% | ||
| Q4 24 | 47.0% | -38.9% | ||
| Q3 24 | 48.3% | -49.5% | ||
| Q2 24 | 54.7% | -40.7% | ||
| Q1 24 | 33.3% | -46.4% |
净利率INVARKLB
| Q4 25 | 143.2% | -29.5% | ||
| Q3 25 | 83.4% | -11.8% | ||
| Q2 25 | 63.5% | -46.0% | ||
| Q1 25 | -52.6% | -49.5% | ||
| Q4 24 | 22.1% | -39.5% | ||
| Q3 24 | 1.4% | -49.6% | ||
| Q2 24 | -34.7% | -39.2% | ||
| Q1 24 | 47.1% | -47.7% |
每股收益（稀释后）INVARKLB
| Q4 25 | $2.19 | $-0.09 | ||
| Q3 25 | $1.08 | $-0.03 | ||
| Q2 25 | $0.77 | $-0.13 | ||
| Q1 25 | $-0.74 | $-0.12 | ||
| Q4 24 | $0.43 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.10 | ||
| Q2 24 | $-0.55 | $-0.08 | ||
| Q1 24 | $0.46 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $550.9M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $1.2B | $1.7B |
| 总资产 | $1.6B | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资INVARKLB
| Q4 25 | $550.9M | $1.0B | ||
| Q3 25 | $476.5M | $976.7M | ||
| Q2 25 | $397.5M | $688.1M | ||
| Q1 25 | $319.1M | $428.4M | ||
| Q4 24 | $305.0M | $419.0M | ||
| Q3 24 | $260.6M | $442.4M | ||
| Q2 24 | $217.0M | $496.8M | ||
| Q1 24 | $178.4M | $492.5M |
总债务INVARKLB
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益INVARKLB
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $714.8M | $688.5M | ||
| Q1 25 | $646.9M | $431.3M | ||
| Q4 24 | $691.2M | $382.5M | ||
| Q3 24 | $668.5M | $419.8M | ||
| Q2 24 | $665.5M | $455.2M | ||
| Q1 24 | $703.7M | $478.9M |
总资产INVARKLB
| Q4 25 | $1.6B | $2.3B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B | ||
| Q1 24 | $1.3B | $1.2B |
负债/权益比INVARKLB
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.5M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-114.2M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | — | 27.6% |
| 现金转化率经营现金流/净利润 | 0.33× | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
经营现金流INVARKLB
| Q4 25 | $54.5M | $-64.5M | ||
| Q3 25 | $49.7M | $-23.5M | ||
| Q2 25 | $44.1M | $-23.2M | ||
| Q1 25 | $48.6M | $-54.2M | ||
| Q4 24 | $59.2M | $-2.4M | ||
| Q3 24 | $48.7M | $-30.9M | ||
| Q2 24 | $43.7M | $-13.0M | ||
| Q1 24 | $37.0M | $-2.6M |
自由现金流INVARKLB
| Q4 25 | — | $-114.2M | ||
| Q3 25 | — | $-69.4M | ||
| Q2 25 | — | $-55.3M | ||
| Q1 25 | — | $-82.9M | ||
| Q4 24 | — | $-23.9M | ||
| Q3 24 | $48.4M | $-41.9M | ||
| Q2 24 | — | $-28.3M | ||
| Q1 24 | — | $-21.8M |
自由现金流率INVARKLB
| Q4 25 | — | -63.6% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | -38.3% | ||
| Q1 25 | — | -67.6% | ||
| Q4 24 | — | -18.1% | ||
| Q3 24 | 54.1% | -40.0% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | — | -23.5% |
资本支出强度INVARKLB
| Q4 25 | — | 27.6% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | 0.0% | 16.3% | ||
| Q3 24 | 0.3% | 10.5% | ||
| Q2 24 | 0.0% | 14.4% | ||
| Q1 24 | 0.0% | 20.7% |
现金转化率INVARKLB
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.91× | — | ||
| Q3 24 | 40.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INVA
| Royalty | $54.9M | 48% |
| Xacduro | $32.1M | 28% |
| Giapreza | $19.6M | 17% |
| Xerava | $7.3M | 6% |
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
